Plasma levels and cerebrospinal fluid penetration by duloxetine in a patient with a non-fatal overdose during a suicide attempt

International Journal of Neuropsychopharmacology

Volumn 12, Issue 10, 2009, Pages 1431-1432

  Paulzen, Michael ^a   Hiemke, Christoph ^b   Gründer, Gerhard ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; DULOXETINE; PIPAMPERONE; THIOPHENE DERIVATIVE;

ADULT; AGITATION; CASE REPORT; CEREBROSPINAL FLUID; DELIRIUM; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG OVERDOSE; FEMALE; HALLUCINATION; HUMAN; LETTER; MAJOR DEPRESSION; PRIORITY JOURNAL; SUICIDE ATTEMPT; BLOOD; INTOXICATION; PSYCHOLOGICAL ASPECT;

ADULT; FEMALE; HUMANS; OVERDOSE; SUICIDE, ATTEMPTED; THIOPHENES;

EID: 77954064762     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145709990484     Document Type: Letter

References (5)

1. Lobo ED, Bergstrom RF, Reddy S, Quinlan T, et al. (2008). In vitro and in vivo evaluations of cytochrome P450 1A2 interactions with duloxetine. Clinical Pharmacokinetics 47, 191-202
2. Menchetti M, Ferrari Gozzi B, Addolorata Saracino M, Mercolini L, et al. (2008). Non-fatal overdose of duloxetine in combination with other antidepressants and benzodiazepines. World Journal of Biological Psychiatry 2, 1-5.
3. Raskin J, Goldstein DJ, Mallinckrodt CH, Ferguson MB (2003). Duloxetine in the long-term treatment of major depressive disorder. Journal of Clinical Psychiatry 64, 1237-1244.
4. Takano A, Suzuki K, Kosaka J, Ota M, et al. (2006). A dosefinding study of duloxetine based on serotonin transporter occupancy. Psychopharmacology (Berlin), 185, 395-399.
5. Wong DT, Bymaster FP, Mayle DA, Reid LR, et al. (1993). LY248686, a new inhibitor of serotonin and norepinephrine uptake. Neuropsychopharmacology 8, 23-33. (Pubitemid 23011155)